| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| trebananib | angiopoietin-1 | NA | Clinical trial target | TTD , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of ovary[MeSHID:D010051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
31.83 | phase 3 | inhibitor |
| trebananib | angiopoietin-2 | NA | Clinical trial target | TTD , DGIDB | Renal Cell Carcinoma[MeSHID:D002292] Malignant Neoplasms[MeSHID:D009369] Malignant neoplasm of ovary[MeSHID:D010051] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
7.96 | phase 3 | inhibitor |
| click here to return to the previous page | ||||||||